Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple Sclerosis
ABSTRACT The expanding therapeutic arsenal in multiple sclerosis (MS) has allowed for more effective and personalized treatment, but the choice and management of disease-modifying therapies (DMTs) is becoming increasingly complex. In this context, experts from the Brazilian Committee on Treatment an...
Saved in:
Similar Items
-
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis
by: Josiane Lopes, et al.
Published: (2016-04-01) -
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers
by: Enedina Maria Lobato de Oliveira, et al.
Published: (2015-09-01) -
Multiple sclerosis risk perception and acceptance for Brazilian patients
by: Denis Bernardi Bichuetti, et al. -
Multiple sclerosis starting before the age of 18 years: the Brazilian experience
by: Yara Dadalti Fragoso, et al.
Published: (2013-10-01) -
Evaluation of diagnosis and treatment practices of Brazilian neurologists among patients with multiple sclerosis
by: Cássia Elisa Marin, et al.
Published: (2021-08-01)